{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:27:01Z","timestamp":1793831221200,"version":"4.6.1"},"reference-count":54,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Large-scale immune monitoring is becoming routinely used in clinical trials to identify determinants of treatment responsiveness, particularly to immunotherapies. Flow cytometry remains one of the most versatile and high throughput approaches for single-cell analysis; however, manual interpretation of multidimensional data poses a challenge when attempting to capture full cellular diversity and provide reproducible results. We present FlowCT, a semi-automated workspace empowered to analyze large data sets. It includes pre-processing, normalization, multiple dimensionality reduction techniques, automated clustering, and predictive modeling tools. As a proof of concept, we used FlowCT to compare the T-cell compartment in bone marrow (BM) with peripheral blood (PB) from patients with smoldering multiple myeloma (SMM), identify minimally invasive immune biomarkers of progression from smoldering to active MM, define prognostic T-cell subsets in the BM of patients with active MM after treatment intensification, and assess the longitudinal effect of maintenance therapy in BM T cells. A total of 354 samples were analyzed and immune signatures predictive of malignant transformation were identified in 150 patients with SMM (hazard ratio [HR], 1.7; P &amp;lt; .001). We also determined progression-free survival (HR, 4.09; P &amp;lt; .0001) and overall survival (HR, 3.12; P = .047) in 100 patients with active MM. New data also emerged about stem cell memory T cells, the concordance between immune profiles in BM and PB, and the immunomodulatory effect of maintenance therapy. FlowCT is a new open-source computational approach that can be readily implemented by research laboratories to perform quality control, analyze high-dimensional data, unveil cellular diversity, and objectively identify biomarkers in large immune monitoring studies. These trials were registered at www.clinicaltrials.gov as #NCT01916252 and #NCT02406144.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021005198","type":"journal-article","created":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T20:09:21Z","timestamp":1632946161000},"page":"690-703","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":43,"title":["FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1522-4504","authenticated-orcid":false,"given":"Cirino","family":"Botta","sequence":"first","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy;"},{"name":"Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra Hematology Unit, Clinica Universidad de Navarra, Centro de Investigaci\u00f3n Biom\u00e9dica en Red, Canc\u00e9r Hematology Unit, Pamplona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Maia","sequence":"additional","affiliation":[{"name":"Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra Hematology Unit, Clinica Universidad de Navarra, Centro de Investigaci\u00f3n Biom\u00e9dica en Red, Canc\u00e9r Hematology Unit, Pamplona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9235-4671","authenticated-orcid":false,"given":"Juan-Jos\u00e9","family":"Garc\u00e9s","sequence":"additional","affiliation":[{"name":"Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra Hematology Unit, Clinica Universidad de Navarra, Centro de Investigaci\u00f3n Biom\u00e9dica en Red, Canc\u00e9r Hematology Unit, Pamplona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinda","family":"Termini","sequence":"additional","affiliation":[{"name":"Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra Hematology Unit, Clinica Universidad de Navarra, Centro de Investigaci\u00f3n Biom\u00e9dica en Red, Canc\u00e9r Hematology Unit, Pamplona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3586-2666","authenticated-orcid":false,"given":"Cristina","family":"Perez","sequence":"additional","affiliation":[{"name":"Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra Hematology Unit, Clinica Universidad de Navarra, Centro de Investigaci\u00f3n Biom\u00e9dica en Red, Canc\u00e9r Hematology Unit, Pamplona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Manrique","sequence":"additional","affiliation":[{"name":"Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra Hematology Unit, Clinica Universidad de Navarra, Centro de Investigaci\u00f3n Biom\u00e9dica en Red, Canc\u00e9r Hematology Unit, Pamplona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0998-2496","authenticated-orcid":false,"given":"Leire","family":"Burgos","sequence":"additional","affiliation":[{"name":"Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra Hematology Unit, Clinica Universidad de Navarra, Centro de Investigaci\u00f3n Biom\u00e9dica en Red, Canc\u00e9r Hematology Unit, Pamplona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aintzane","family":"Zabaleta","sequence":"additional","affiliation":[{"name":"Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra Hematology Unit, Clinica Universidad de Navarra, Centro de Investigaci\u00f3n Biom\u00e9dica en Red, Canc\u00e9r Hematology Unit, Pamplona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Alignani","sequence":"additional","affiliation":[{"name":"Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra Hematology Unit, Clinica Universidad de Navarra, Centro de Investigaci\u00f3n Biom\u00e9dica en Red, Canc\u00e9r Hematology Unit, Pamplona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarai","family":"Sarvide","sequence":"additional","affiliation":[{"name":"Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra Hematology Unit, Clinica Universidad de Navarra, Centro de Investigaci\u00f3n Biom\u00e9dica en Red, Canc\u00e9r Hematology Unit, Pamplona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juana","family":"Merino","sequence":"additional","affiliation":[{"name":"Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra Hematology Unit, Clinica Universidad de Navarra, Centro de Investigaci\u00f3n Biom\u00e9dica en Red, Canc\u00e9r Hematology Unit, Pamplona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7535-3861","authenticated-orcid":false,"given":"Noemi","family":"Puig","sequence":"additional","affiliation":[{"name":"Hospital Universitario de Salamanca Hematolog\u00eda, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda-Teresa","family":"Cedena","sequence":"additional","affiliation":[{"name":"Hospital Universitario 12 de Octubre, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7258-475X","authenticated-orcid":false,"given":"Marco","family":"Rossi","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Medicine Department, \u201cMagna Graecia\u201d University, Catanzaro, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierfrancesco","family":"Tassone","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Medicine Department, \u201cMagna Graecia\u201d University, Catanzaro, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Gentile","sequence":"additional","affiliation":[{"name":"Hematology Unit, Department of Oncology, \u201cAnnunziata\u201d Hospital of Cosenza, Cosenza, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"Correale","sequence":"additional","affiliation":[{"name":"Medical Oncology Unit, Great Metropolitan Hospital \u201cRiuniti\u201d of Reggio Calabria, Reggio Calabria, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7316-8862","authenticated-orcid":false,"given":"Ivan","family":"Borrello","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5133-1422","authenticated-orcid":false,"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[{"name":"Department of Clinical Therapeutics, Alexandra General Hospital, National and Kapodistrian University of Athens School of Medicine, Athens, Greece;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5467-9253","authenticated-orcid":false,"given":"Tomas","family":"Jelinek","sequence":"additional","affiliation":[{"name":"Department of Haemato-oncology, University Hospital Ostrava, Ostrava, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Paiva","sequence":"additional","affiliation":[{"name":"Unidade de Gest\u00e3o Operacional de Citometria, Centro Hospitalar e Universit\u00e1rio de Coimbra, Coimbra, Portugal;"},{"name":"Faculty of Medicine, Coimbra Institute for Clinical and Biomedical Research, University of Coimbra, Coimbra, Portugal;"},{"name":"Ci\u00eancias Biom\u00e9dicas Laboratoriais, Escola Superior de Tecnologia da Sa\u00fade de Coimbra, Instituto Polit\u00e9cnico de Coimbra, Coimbra, Portugal;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Roccaro","sequence":"additional","affiliation":[{"name":"Clinical Research Development and Phase I Unit, Azienda Socio Sanitaria Territoriale Spedali Civili di Brescia, Brescia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0961-0035","authenticated-orcid":false,"given":"Hartmut","family":"Goldschmidt","sequence":"additional","affiliation":[{"name":"University Hospital Heidelberg, Internal Medicine V and National Center for Tumor Diseases, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3050-0140","authenticated-orcid":false,"given":"Herv\u00e9","family":"Avet-Loiseau","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Canc\u00e9rologie de Toulouse, Unit\u00e9 1037, INSERM, Toulouse, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2534-9239","authenticated-orcid":false,"given":"Laura","family":"Rosinol","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednic, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2390-1218","authenticated-orcid":false,"given":"Maria-Victoria","family":"Mateos","sequence":"additional","affiliation":[{"name":"Hospital Universitario de Salamanca Hematolog\u00eda, Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca, Salamanca, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Martinez-Lopez","sequence":"additional","affiliation":[{"name":"Hospital Universitario 12 de Octubre, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3393-9570","authenticated-orcid":false,"given":"Juan-Jos\u00e9","family":"Lahuerta","sequence":"additional","affiliation":[{"name":"Hospital Universitario 12 de Octubre, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Blad\u00e9","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednic, Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9183-4857","authenticated-orcid":false,"given":"Jes\u00fas F.","family":"San-Miguel","sequence":"additional","affiliation":[{"name":"Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra Hematology Unit, Clinica Universidad de Navarra, Centro de Investigaci\u00f3n Biom\u00e9dica en Red, Canc\u00e9r Hematology Unit, Pamplona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1977-3815","authenticated-orcid":false,"given":"Bruno","family":"Paiva,","sequence":"additional","affiliation":[{"name":"Centro de Investigacion Medica Aplicada, Instituto de Investigacion Sanitaria de Navarra Hematology Unit, Clinica Universidad de Navarra, Centro de Investigaci\u00f3n Biom\u00e9dica en Red, Canc\u00e9r Hematology Unit, Pamplona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,1,24]]},"reference":[{"issue":"1","key":"2022012416244204800_B1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood-2017-06-741058","article-title":"Redirecting T cells to hematological malignancies with bispecific antibodies","volume":"131","author":"Velasquez","year":"2018","journal-title":"Blood."},{"issue":"1","key":"2022012416244204800_B2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-018-0601-9","article-title":"Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma","volume":"11","author":"Wang","year":"2018","journal-title":"J Hematol Oncol."},{"issue":"7","key":"2022012416244204800_B3","doi-asserted-by":"crossref","first-page":"e2299","DOI":"10.1038\/cddis.2016.211","article-title":"The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response","volume":"7","author":"Botta","year":"2016","journal-title":"Cell Death Dis."},{"issue":"2","key":"2022012416244204800_B4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41577-020-0275-8","article-title":"Dissecting the mechanisms of immune checkpoint therapy","volume":"20","author":"Sharma","year":"2020","journal-title":"Nat Rev Immunol."},{"issue":"24","key":"2022012416244204800_B5","doi-asserted-by":"crossref","first-page":"12472","DOI":"10.18632\/oncotarget.2998","article-title":"Classification of current anticancer immunotherapies","volume":"5","author":"Galluzzi","year":"2014","journal-title":"Oncotarget."},{"issue":"12","key":"2022012416244204800_B6","doi-asserted-by":"crossref","first-page":"e511","DOI":"10.1038\/bcj.2016.118","article-title":"A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival","volume":"6","author":"Botta","year":"2016","journal-title":"Blood Cancer J."},{"issue":"7","key":"2022012416244204800_B7","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/s41375-018-0175-0","article-title":"Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML","volume":"32","author":"Br\u00fcck","year":"2018","journal-title":"Leukemia."},{"issue":"3","key":"2022012416244204800_B8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ccell.2020.06.002","article-title":"Immunogenomic landscape of hematological malignancies","volume":"38","author":"Dufva","year":"2020","journal-title":"Cancer Cell."},{"issue":"9","key":"2022012416244204800_B9","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1182\/blood-2015-10-662320","article-title":"Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis","volume":"127","author":"Paiva","year":"2016","journal-title":"Blood."},{"issue":"2","key":"2022012416244204800_B10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1182\/blood.2019004537","article-title":"Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma","volume":"136","author":"Perez","year":"2020","journal-title":"Blood."},{"issue":"10","key":"2022012416244204800_B11","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1038\/s41375-019-0441-9","article-title":"CD8+ T cells expand stem and progenitor cells in favorable but not adverse risk acute myeloid leukemia","volume":"33","author":"Radpour","year":"2019","journal-title":"Leukemia."},{"issue":"34","key":"2022012416244204800_B12","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1200\/JCO.18.02365","article-title":"Progression of disease within 24 months in follicular lymphoma is associated with reduced intratumoral immune infiltration","volume":"37","author":"Tobin","year":"2019","journal-title":"J Clin Oncol."},{"issue":"6","key":"2022012416244204800_B13","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ccell.2020.04.015","article-title":"Extensive remodeling of the immune microenvironment in B cell acute lymphoblastic leukemia","volume":"37","author":"Witkowski","year":"2020","journal-title":"Cancer Cell."},{"issue":"3","key":"2022012416244204800_B14","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ccell.2020.08.013","article-title":"A multi-layer molecular fresco of the immune diversity across hematologic malignancies","volume":"38","author":"Bedognetti","year":"2020","journal-title":"Cancer Cell."},{"issue":"7","key":"2022012416244204800_B15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nri.2016.56","article-title":"Computational flow cytometry: helping to make sense of high-dimensional immunology data","volume":"16","author":"Saeys","year":"2016","journal-title":"Nat Rev Immunol."},{"issue":"8","key":"2022012416244204800_B16","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/cyto.a.24158","article-title":"A cancer biologist\u2019s primer on machine learning applications in high-dimensional cytometry","volume":"97","author":"Keyes","year":"2020","journal-title":"Cytometry A."},{"key":"2022012416244204800_B17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s12859-020-03671-7","article-title":"Model-based clustering for flow and mass cytometry data with clinical information","volume":"21","author":"Abe","year":"2020","journal-title":"BMC Bioinformatics."},{"issue":"7","key":"2022012416244204800_B18","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/cyto.a.22625","article-title":"FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data","volume":"87","author":"Van Gassen","year":"2015","journal-title":"Cytometry A."},{"key":"2022012416244204800_B19","doi-asserted-by":"crossref","first-page":"748","DOI":"10.12688\/f1000research.11622.1","article-title":"CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets","volume":"6","author":"Nowicka","year":"2017","journal-title":"F1000 Res."},{"issue":"8","key":"2022012416244204800_B20","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/cyto.a.24016","article-title":"High-dimensional data analysis algorithms yield comparable results for mass cytometry and spectral flow cytometry data","volume":"97","author":"Ferrer-Font","year":"2020","journal-title":"Cytometry A."},{"issue":"9","key":"2022012416244204800_B21","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1093\/bioinformatics\/btaa042","article-title":"PARC: ultrafast and accurate clustering of phenotypic data of millions of single cells","volume":"36","author":"Stassen","year":"2020","journal-title":"Bioinformatics."},{"issue":"10","key":"2022012416244204800_B22","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1093\/bioinformatics\/btaa091","article-title":"ShinySOM: graphical SOM-based analysis of single-cell cytometry data","volume":"36","author":"Kratochv\u00edl","year":"2020","journal-title":"Bioinformatics."},{"issue":"16","key":"2022012416244204800_B23","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1093\/bioinformatics\/btw191","article-title":"flowAI: automatic and interactive anomaly discerning tools for flow cytometry data","volume":"32","author":"Monaco","year":"2016","journal-title":"Bioinformatics."},{"issue":"8","key":"2022012416244204800_B24","doi-asserted-by":"crossref","first-page":"e1003806","DOI":"10.1371\/journal.pcbi.1003806","article-title":"OpenCyto: an open source infrastructure for scalable, robust, reproducible, and automated, end-to-end flow cytometry data analysis","volume":"10","author":"Finak","year":"2014","journal-title":"PLOS Comput Biol."},{"issue":"1","key":"2022012416244204800_B25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4049\/jimmunol.2000854","article-title":"Multibatch cytometry data integration for optimal immunophenotyping","volume":"206","author":"Ogishi","year":"2021","journal-title":"J Immunol."},{"issue":"3","key":"2022012416244204800_B26","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/cyto.a.23904","article-title":"CytoNorm: a normalization algorithm for cytometry data","volume":"97","author":"Van Gassen","year":"2020","journal-title":"Cytometry A."},{"key":"2022012416244204800_B27","doi-asserted-by":"crossref","DOI":"10.1101\/2020.09.09.289033","article-title":"ImmunoCluster: a computational framework for the non-specialist to profile cellular heterogeneity in cytometry datasets","volume-title":"bioRxiv.","author":"Opzoomer","year":"2020"},{"key":"2022012416244204800_B28","doi-asserted-by":"crossref","DOI":"10.1101\/2020.10.22.349563","article-title":"Integration, exploration, and analysis of high-dimensional single-cell cytometry data using Spectre","volume-title":"bioRxiv.","author":"Ashhurst","year":"2020"},{"issue":"5","key":"2022012416244204800_B29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s43018-020-0053-3","article-title":"Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma","volume":"1","author":"Zavidij","year":"2020","journal-title":"Nat Cancer."},{"issue":"13","key":"2022012416244204800_B30","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.3390\/cancers13133213","article-title":"Mechanisms of immune evasion in multiple myeloma: Open questions and therapeutic opportunities","volume":"13","author":"Botta","year":"2021","journal-title":"Cancers (Basel)."},{"issue":"9","key":"2022012416244204800_B31","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1182\/blood.2020008209","article-title":"Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed\/refractory multiple myeloma","volume":"137","author":"Dimopoulos","year":"2021","journal-title":"Blood."},{"issue":"8","key":"2022012416244204800_B32","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1200\/JCO.19.01231","article-title":"Measurable residual disease by next-generation flow cytometry in multiple myeloma","volume":"38","author":"Paiva","year":"2020","journal-title":"J Clin Oncol."},{"issue":"16","key":"2022012416244204800_B33","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1182\/blood.2019000241","article-title":"Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma","volume":"134","author":"Rosi\u00f1ol","year":"2019","journal-title":"Blood."},{"issue":"9","key":"2022012416244204800_B34","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/leu.2012.122","article-title":"EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols","volume":"26","author":"Kalina","year":"2012","journal-title":"Leukemia."},{"issue":"1","key":"2022012416244204800_B35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics."},{"issue":"2","key":"2022012416244204800_B36","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq \u2013 a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics."},{"issue":"12","key":"2022012416244204800_B37","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"2022012416244204800_B38","article-title":"DEGreport: Report of DEG analysis","author":"Pantano"},{"issue":"23","key":"2022012416244204800_B39","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1182\/blood-2016-09-692954","article-title":"MGUS to myeloma: a mysterious gammopathy of underexplored significance","volume":"128","author":"Dhodapkar","year":"2016","journal-title":"Blood."},{"issue":"1","key":"2022012416244204800_B40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3324\/haematol.2012.067272","article-title":"Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry","volume":"98","author":"Pessoa de Magalh\u00e3es","year":"2013","journal-title":"Haematologica."},{"issue":"1","key":"2022012416244204800_B41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1182\/blood-2013-07-515239","article-title":"Clinical, genomic, and imaging predictors of myeloma progression from asymptomatic monoclonal gammopathies (SWOG S0120)","volume":"123","author":"Dhodapkar","year":"2014","journal-title":"Blood."},{"issue":"1","key":"2022012416244204800_B42","doi-asserted-by":"crossref","first-page":"20410","DOI":"10.1038\/s41598-020-77220-w","article-title":"A comparison of machine learning methods for survival analysis of high-dimensional clinical data for dementia prediction","volume":"10","author":"Spooner","year":"2020","journal-title":"Sci Rep."},{"key":"2022012416244204800_B43","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3389\/fimmu.2019.01515","article-title":"Meeting the challenges of high-dimensional single-cell data analysis in immunology","volume":"10","author":"Palit","year":"2019","journal-title":"Front Immunol."},{"issue":"5","key":"2022012416244204800_B44","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat Biotechnol."},{"issue":"6","key":"2022012416244204800_B45","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ccell.2020.09.006","article-title":"Cancer biomarkers and big data: a planetary science approach","volume":"38","author":"Crichton","year":"2020","journal-title":"Cancer Cell."},{"issue":"12","key":"2022012416244204800_B46","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/cyto.a.23030","article-title":"Comparison of clustering methods for high-dimensional single-cell flow and mass cytometry data","volume":"89","author":"Weber","year":"2016","journal-title":"Cytometry A."},{"issue":"1","key":"2022012416244204800_B47","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1038\/s41467-019-13056-x","article-title":"The art of using t-SNE for single-cell transcriptomics","volume":"10","author":"Kobak","year":"2019","journal-title":"Nat Commun."},{"issue":"12","key":"2022012416244204800_B48","doi-asserted-by":"crossref","first-page":"e204759","DOI":"10.1001\/jamaoncol.2020.4759","article-title":"Effect of integrating machine learning mortality estimates with behavioral nudges to clinicians on serious illness conversations among patients with cancer: a stepped-wedge cluster randomized clinical trial","volume":"6","author":"Manz","year":"2020","journal-title":"JAMA Oncol."},{"key":"2022012416244204800_B49","article-title":"SurvBoost: an R package for high-dimensional variable selection in the stratified proportional hazards model via gradient boosting","author":"Morris","year":"2018"},{"key":"2022012416244204800_B50","article-title":"ggRandomForests: exploring random forest survival","author":"Ehrlinger","year":"2016"},{"key":"2022012416244204800_B51","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fmolb.2016.00026","article-title":"biosigner: A new method for the discovery of significant molecular signatures from omics data","volume":"3","author":"Rinaudo","year":"2016","journal-title":"Front Mol Biosci."},{"issue":"16","key":"2022012416244204800_B52","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1182\/blood-2018-01-825240","article-title":"Myeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockade","volume":"132","author":"Minnie","year":"2018","journal-title":"Blood."},{"issue":"10","key":"2022012416244204800_B53","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41408-020-00366-3","article-title":"International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)","volume":"10","author":"Mateos","year":"2020","journal-title":"Blood Cancer J."},{"issue":"4","key":"2022012416244204800_B54","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nm.4505","article-title":"Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse","volume":"24","author":"Good","year":"2018","journal-title":"Nat Med."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/2\/690\/1862863\/advancesadv2021005198.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/2\/690\/1862863\/advancesadv2021005198.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T16:26:11Z","timestamp":1643041571000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/2\/690\/477072\/FlowCT-for-the-analysis-of-large-immunophenotypic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,24]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,1,25]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021005198","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,24]]}}}